Developer of gene therapy treatments. The company is engaged in research and development of treatments and drugs from gene therapy for diseases using molecular imaging techniques such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Gene Therapy Research Institution Company‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Katsuhito Asai | President | ||
Shinichi Muramatsu | Director | ||
Toshihiko Sato | Director |
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000-0000000000 0 | 02-Aug-2017 | 00000 0000000 | Biotechnology | 000000000 0000 |